ED
WGS icon

Exane Derivatives’s GeneDx Holdings WGS Stock Holding History

Exane Derivatives’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$78.3K Buy
+1,883
New +$128K 0.05% 284
2022
Q1 		– Sell
-1,883
Closed -$277K – 1091
2021
Q4 		$277K Buy
1,883
+618
+49% +$138K 0.07% 275
2021
Q3 		$317K Buy
1,265
+622
+97% +$214K 0.08% 275
2021
Q2 		$261K Buy
643
+288
+81% +$124K 0.06% 327
2021
Q1 		$174K Buy
+355
New +$185K 0.05% 322

Other funds holding WGS

Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Exane Derivatives's WGS Position: Q2 2022 in Review

Exane Derivatives opened a new position in GeneDx Holdings (WGS) in Q2 2022: 1,883 shares worth $78.3K. The stake represents 0.05% of the portfolio and ranks #284 among its holdings. This is a return to the name: Exane Derivatives previously reported a position in WGS as recently as Q4 2021.

Exane Derivatives first reported a position in WGS in Q1 2021 and has held it in 5 quarters since. The position peaked at $317K in Q3 2021. 111 funds tracked by Wall St. Rank hold WGS as of Q2 2022.

  • Exane Derivatives held 1,883 shares of GeneDx Holdings worth $78.3K as of Q2 2022.
  • GeneDx Holdings was a new Exane Derivatives position in Q2 2022.
  • GeneDx Holdings made up 0.05% of Exane Derivatives's portfolio in Q2 2022, its #284 holding.
  • Exane Derivatives first reported a position in GeneDx Holdings in Q1 2021 and has held it in 5 quarters since.
  • Exane Derivatives's GeneDx Holdings position peaked at $317K in Q3 2021.
  • 111 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.